Anti-inflammatory activity of Terminalia paniculata bark extract against acute and chronic inflammation in rats

Sahil Talwar, K. Nandakumar, Pawan G. Nayak, Punit Bansal, Jayesh Mudgal, Vijay Mor, Chamallamudi Mallikarjuna Rao, Richard Lobo

Research output: Contribution to journalArticle

32 Citations (Scopus)

Abstract

Ethnopharmacological relevance: Terminalia paniculata Roxb. (Family-Combretaceae) is a wild tree commonly used in traditional ayurvedic medicine for the treatment of inflammation of parotid glands and in menstrual disorders. Aim of the study: To explore the folk use of Terminalia paniculata on pharmacological grounds to evaluate the scientific basis of anti-inflammatory activity. Materials and methods: The anti-inflammatory activity of Terminalia paniculata was studied against carrageenan-induced hind paw edema, air pouch inflammation and complete Freund's adjuvant (CFA)-induced arthritis in rats. The aqueous extract of Terminalia paniculata bark (TPW) was administered at the concentrations of 100, 200 and 400 mg/kg body weight. Results: TPW showed significant (p < 0.05) anti-inflammatory activity by reducing the edema volume in carrageenan-induced paw edema in rats. Further, TPW (400 mg/kg) also reduced the carrageenan-induced leukocyte migration (50.92 ± 5.71%) and myeloperoxidase activity (49.31 ± 5.24%) in air pouch exudates. TPW (200 mg/kg) exhibits anti-rheumatic and analgesic activities by improving the altered haematological milieu (ESR, CRP, RF, WBC, RBC and Hb) and also by inhibiting the flexion scores and radiographic changes in CFA-induced arthritis. This extract also had significant (p < 0.05) effects on the occurrence of secondary lesions compared to CFA control. Conclusions: Terminalia paniculata bark may be a potential preventive or therapeutic candidate for the treatment of chronic inflammation and arthritis.

Original languageEnglish
Pages (from-to)323-328
Number of pages6
JournalJournal of Ethnopharmacology
Volume134
Issue number2
DOIs
Publication statusPublished - 24-03-2011

Fingerprint

Terminalia
Anti-Inflammatory Agents
Freund's Adjuvant
Carrageenan
Inflammation
Edema
Experimental Arthritis
Combretaceae
Air
Ayurvedic Medicine
Parotid Gland
Traditional Medicine
Exudates and Transudates
Peroxidase
Arthritis
Analgesics
Leukocytes
Therapeutics
Body Weight
Pharmacology

All Science Journal Classification (ASJC) codes

  • Pharmacology
  • Drug Discovery

Cite this

@article{c79b5c8445d54e499372d49834bb3622,
title = "Anti-inflammatory activity of Terminalia paniculata bark extract against acute and chronic inflammation in rats",
abstract = "Ethnopharmacological relevance: Terminalia paniculata Roxb. (Family-Combretaceae) is a wild tree commonly used in traditional ayurvedic medicine for the treatment of inflammation of parotid glands and in menstrual disorders. Aim of the study: To explore the folk use of Terminalia paniculata on pharmacological grounds to evaluate the scientific basis of anti-inflammatory activity. Materials and methods: The anti-inflammatory activity of Terminalia paniculata was studied against carrageenan-induced hind paw edema, air pouch inflammation and complete Freund's adjuvant (CFA)-induced arthritis in rats. The aqueous extract of Terminalia paniculata bark (TPW) was administered at the concentrations of 100, 200 and 400 mg/kg body weight. Results: TPW showed significant (p < 0.05) anti-inflammatory activity by reducing the edema volume in carrageenan-induced paw edema in rats. Further, TPW (400 mg/kg) also reduced the carrageenan-induced leukocyte migration (50.92 ± 5.71{\%}) and myeloperoxidase activity (49.31 ± 5.24{\%}) in air pouch exudates. TPW (200 mg/kg) exhibits anti-rheumatic and analgesic activities by improving the altered haematological milieu (ESR, CRP, RF, WBC, RBC and Hb) and also by inhibiting the flexion scores and radiographic changes in CFA-induced arthritis. This extract also had significant (p < 0.05) effects on the occurrence of secondary lesions compared to CFA control. Conclusions: Terminalia paniculata bark may be a potential preventive or therapeutic candidate for the treatment of chronic inflammation and arthritis.",
author = "Sahil Talwar and K. Nandakumar and Nayak, {Pawan G.} and Punit Bansal and Jayesh Mudgal and Vijay Mor and Rao, {Chamallamudi Mallikarjuna} and Richard Lobo",
year = "2011",
month = "3",
day = "24",
doi = "10.1016/j.jep.2010.12.015",
language = "English",
volume = "134",
pages = "323--328",
journal = "Journal of Ethnopharmacology",
issn = "0378-8741",
publisher = "Elsevier Ireland Ltd",
number = "2",

}

Anti-inflammatory activity of Terminalia paniculata bark extract against acute and chronic inflammation in rats. / Talwar, Sahil; Nandakumar, K.; Nayak, Pawan G.; Bansal, Punit; Mudgal, Jayesh; Mor, Vijay; Rao, Chamallamudi Mallikarjuna; Lobo, Richard.

In: Journal of Ethnopharmacology, Vol. 134, No. 2, 24.03.2011, p. 323-328.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Anti-inflammatory activity of Terminalia paniculata bark extract against acute and chronic inflammation in rats

AU - Talwar, Sahil

AU - Nandakumar, K.

AU - Nayak, Pawan G.

AU - Bansal, Punit

AU - Mudgal, Jayesh

AU - Mor, Vijay

AU - Rao, Chamallamudi Mallikarjuna

AU - Lobo, Richard

PY - 2011/3/24

Y1 - 2011/3/24

N2 - Ethnopharmacological relevance: Terminalia paniculata Roxb. (Family-Combretaceae) is a wild tree commonly used in traditional ayurvedic medicine for the treatment of inflammation of parotid glands and in menstrual disorders. Aim of the study: To explore the folk use of Terminalia paniculata on pharmacological grounds to evaluate the scientific basis of anti-inflammatory activity. Materials and methods: The anti-inflammatory activity of Terminalia paniculata was studied against carrageenan-induced hind paw edema, air pouch inflammation and complete Freund's adjuvant (CFA)-induced arthritis in rats. The aqueous extract of Terminalia paniculata bark (TPW) was administered at the concentrations of 100, 200 and 400 mg/kg body weight. Results: TPW showed significant (p < 0.05) anti-inflammatory activity by reducing the edema volume in carrageenan-induced paw edema in rats. Further, TPW (400 mg/kg) also reduced the carrageenan-induced leukocyte migration (50.92 ± 5.71%) and myeloperoxidase activity (49.31 ± 5.24%) in air pouch exudates. TPW (200 mg/kg) exhibits anti-rheumatic and analgesic activities by improving the altered haematological milieu (ESR, CRP, RF, WBC, RBC and Hb) and also by inhibiting the flexion scores and radiographic changes in CFA-induced arthritis. This extract also had significant (p < 0.05) effects on the occurrence of secondary lesions compared to CFA control. Conclusions: Terminalia paniculata bark may be a potential preventive or therapeutic candidate for the treatment of chronic inflammation and arthritis.

AB - Ethnopharmacological relevance: Terminalia paniculata Roxb. (Family-Combretaceae) is a wild tree commonly used in traditional ayurvedic medicine for the treatment of inflammation of parotid glands and in menstrual disorders. Aim of the study: To explore the folk use of Terminalia paniculata on pharmacological grounds to evaluate the scientific basis of anti-inflammatory activity. Materials and methods: The anti-inflammatory activity of Terminalia paniculata was studied against carrageenan-induced hind paw edema, air pouch inflammation and complete Freund's adjuvant (CFA)-induced arthritis in rats. The aqueous extract of Terminalia paniculata bark (TPW) was administered at the concentrations of 100, 200 and 400 mg/kg body weight. Results: TPW showed significant (p < 0.05) anti-inflammatory activity by reducing the edema volume in carrageenan-induced paw edema in rats. Further, TPW (400 mg/kg) also reduced the carrageenan-induced leukocyte migration (50.92 ± 5.71%) and myeloperoxidase activity (49.31 ± 5.24%) in air pouch exudates. TPW (200 mg/kg) exhibits anti-rheumatic and analgesic activities by improving the altered haematological milieu (ESR, CRP, RF, WBC, RBC and Hb) and also by inhibiting the flexion scores and radiographic changes in CFA-induced arthritis. This extract also had significant (p < 0.05) effects on the occurrence of secondary lesions compared to CFA control. Conclusions: Terminalia paniculata bark may be a potential preventive or therapeutic candidate for the treatment of chronic inflammation and arthritis.

UR - http://www.scopus.com/inward/record.url?scp=79952697685&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=79952697685&partnerID=8YFLogxK

U2 - 10.1016/j.jep.2010.12.015

DO - 10.1016/j.jep.2010.12.015

M3 - Article

VL - 134

SP - 323

EP - 328

JO - Journal of Ethnopharmacology

JF - Journal of Ethnopharmacology

SN - 0378-8741

IS - 2

ER -